Jingxia Du

614 total citations
21 papers, 481 citations indexed

About

Jingxia Du is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Jingxia Du has authored 21 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Jingxia Du's work include Retinal Diseases and Treatments (3 papers), Adipose Tissue and Metabolism (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Jingxia Du is often cited by papers focused on Retinal Diseases and Treatments (3 papers), Adipose Tissue and Metabolism (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Jingxia Du collaborates with scholars based in China and United States. Jingxia Du's co-authors include Gaofeng Liang, Shuying Feng, E Song, Manhui Zhu, Xun Xu, Xiaodong Sun, Aifang Li, Man‐Wen Jin, Lina Hu and Ying Wang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Applied Microbiology and Biotechnology.

In The Last Decade

Jingxia Du

21 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingxia Du China 14 244 73 69 55 50 21 481
Chunyan Li China 15 338 1.4× 36 0.5× 31 0.4× 23 0.4× 132 2.6× 48 648
Wencan Wu China 12 179 0.7× 85 1.2× 76 1.1× 23 0.4× 55 1.1× 31 535
Yen-Cheng Chen Taiwan 12 113 0.5× 28 0.4× 28 0.4× 34 0.6× 10 0.2× 23 400
Elvira L. Liclican United States 9 134 0.5× 58 0.8× 12 0.2× 62 1.1× 48 1.0× 15 433
Yun Sun China 8 380 1.6× 88 1.2× 64 0.9× 51 0.9× 174 3.5× 11 732
Xiaofei Feng China 12 218 0.9× 27 0.4× 50 0.7× 59 1.1× 71 1.4× 31 458
Yan‐dan Zhou China 9 197 0.8× 76 1.0× 43 0.6× 35 0.6× 27 0.5× 11 435
Junxiu Zhang China 11 213 0.9× 29 0.4× 44 0.6× 32 0.6× 57 1.1× 25 450
Dan Song China 14 180 0.7× 80 1.1× 54 0.8× 20 0.4× 70 1.4× 41 497

Countries citing papers authored by Jingxia Du

Since Specialization
Citations

This map shows the geographic impact of Jingxia Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxia Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxia Du more than expected).

Fields of papers citing papers by Jingxia Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingxia Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxia Du. The network helps show where Jingxia Du may publish in the future.

Co-authorship network of co-authors of Jingxia Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jingxia Du. A scholar is included among the top collaborators of Jingxia Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingxia Du. Jingxia Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Du, Jingxia, et al.. (2024). Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease. Current Issues in Molecular Biology. 46(8). 8031–8052. 13 indexed citations
3.
Du, Jingxia, Hongchao Li, Jingjing Song, et al.. (2022). AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics. Frontiers in Pharmacology. 13. 862204–862204. 37 indexed citations
4.
Wu, Jianzhao, Jingxia Du, Zhi Li, et al.. (2022). Pentamethylquercetin Regulates Lipid Metabolism by Modulating Skeletal Muscle-Adipose Tissue Crosstalk in Obese Mice. Pharmaceutics. 14(6). 1159–1159. 7 indexed citations
5.
Hu, Lina, et al.. (2021). CRISPR/Cas9-induced β-carotene hydroxylase mutation in Dunaliella salina CCAP19/18. AMB Express. 11(1). 83–83. 33 indexed citations
6.
Feng, Shuying, Lina Hu, Qihang Zhang, et al.. (2020). CRISPR/Cas technology promotes the various application of Dunaliella salina system. Applied Microbiology and Biotechnology. 104(20). 8621–8630. 19 indexed citations
7.
Du, Jingxia, Ying Wang, Yuanyuan Tu, et al.. (2020). A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells. Experimental Eye Research. 196. 108065–108065. 44 indexed citations
8.
Li, Zhi, Cai Zhang, Jingxia Du, et al.. (2020). Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling. Cancer Cell International. 20(1). 179–179. 30 indexed citations
9.
Du, Jingxia, Wei He, Jianzhao Wu, et al.. (2020). Pentamethylquercetin Attenuates Cardiac Remodeling via Activation of the Sestrins/Keap1/Nrf2 Pathway in MSG‐Induced Obese Mice. BioMed Research International. 2020(1). 24 indexed citations
10.
Liang, Gaofeng, Haojie Wang, Hao Shi, et al.. (2020). Porphyromonas gingivalis Promotes the Proliferation and Migration of Esophageal Squamous Cell Carcinoma through the miR-194/GRHL3/PTEN/Akt Axis. ACS Infectious Diseases. 6(5). 871–881. 33 indexed citations
11.
Du, Jingxia, Mengxi Zhu, Hongchao Li, et al.. (2020). Metformin attenuates cardiac remodeling in mice through the Nrf2/Keap1 signaling pathway. Experimental and Therapeutic Medicine. 20(2). 838–845. 17 indexed citations
12.
Tu, Yuanyuan, Ying Wang, Xun Xu, et al.. (2019). Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization. Biomedicine & Pharmacotherapy. 121. 109606–109606. 51 indexed citations
13.
Wang, Wan, Lina Hu, Yu Liu, et al.. (2019). An exploration of the rapid transformation method for Dunaliella salina system. AMB Express. 9(1). 181–181. 9 indexed citations
14.
Du, Jingxia, Jianzhao Wu, Zhi Li, et al.. (2019). Pentamethylquercetin protects against cardiac remodeling via activation of Sestrin2. Biochemical and Biophysical Research Communications. 512(2). 412–420. 28 indexed citations
15.
Wang, Li, Xiaodong Sun, Manhui Zhu, et al.. (2019). Epigallocatechin-3-gallate stimulates autophagy and reduces apoptosis levels in retinal Müller cells under high-glucose conditions. Experimental Cell Research. 380(2). 149–158. 45 indexed citations
16.
Shi, Hao, Gaofeng Liang, Yang Li, et al.. (2019). Preparation and Evaluation of Upconversion Nanoparticles Based miRNA Delivery Carrier in Colon Cancer Mice Model. Journal of Biomedical Nanotechnology. 15(11). 2240–2250. 11 indexed citations
17.
Feng, Shuying, et al.. (2018). Meta-analysis of antiviral protection of white spot syndrome virus vaccine to the shrimp. Fish & Shellfish Immunology. 81. 260–265. 9 indexed citations
18.
Liu, Ke, et al.. (2017). MicroRNA‑21 regulates the viability and apoptosis of diffuse large B‑cell lymphoma cells by upregulating B cell lymphoma‑2. Experimental and Therapeutic Medicine. 14(5). 4489–4496. 20 indexed citations
19.
Ma, Junjie, et al.. (2016). Serum adiponectin levels are inversely correlated with leukemia: A meta-analysis. Journal of Cancer Research and Therapeutics. 12(2). 897–902. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026